Alternative Paths to Xenotransplantation

A number of new biotechnology companies are developing pigs with human genes that will partially mask the foreignness of their organs to allow them to be transplanted into humans. Others, however, are closely studying the immune-system biochemistries of pigs and humans to find more classical, drug-based approaches to effective xenotransplantation. The first aim in both cases is the same -- to defeat the devastating and nearly immediate hyperacute rejection of pig organs by the human immune sys

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Others, however, are closely studying the immune-system biochemistries of pigs and humans to find more classical, drug-based approaches to effective xenotransplantation. The first aim in both cases is the same -- to defeat the devastating and nearly immediate hyperacute rejection of pig organs by the human immune system, orchestrated by antibodies and involving powerful complement proteins, that otherwise occurs.

For example, T Cell Sciences Inc., a publicly traded biotech in Needham, Mass., is working on an injectable complement inhibitor, a substance the company calls sCR1, or soluble complement receptor type 1. This agent is a soluble form of the naturally occurring complement regulator CR1, which occurs on the surface of red cells. The soluble form has been liberated from the cell surface and can be administered intravenously.

LOOKING TOWARD TOLERANCE: Novel drug therapies could get xenotransplant patients over the organ-rejection "hump" to immune accommodation, syas T Cell Sciences' vice president ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Franklin Hoke

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio